Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2015/186716 http://scihub22266oqcxt.onion/10.1155/2015/186716 C4499375!4499375!26221578     free     free     free       Anal+Cell+Pathol+(Amst) 2015 ; 2015 (ä): ä Nephropedia Template TP {{tp|p=26221578|t=2015. Use of miRNAs as Biomarkers in Sepsis |pdf=|usr=}}{{26221578}} gab.com Text Use of miRNAs as Biomarkers in Sepsis JO: Anal Cell Pathol (Amst) http://www.kidney.de/pget.php?&tw=1&pmid=26221578 #FOAvip Sepsis is one of the most common causes of death in critical patients. Severe generalized inflammation, infections, and severe physiological imbalances significantly decrease the survival rate with more than 50%. Moreover, monitoring, evaluation, and therapy management often become extremely difficult for the clinician in this type of patients. Current methods of diagnosing sepsis vary based especially on the determination of biochemical-humoral markers, such as cytokines, components of the complement, and proinflammatory and anti-inflammatory compounds. Recent studies highlight the use of new biomarkers for sepsis, namely, miRNAs. miRNAs belong to a class of small, noncoding RNAs with an approximate content of 19?23 nucleotides. Following biochemical and physiological imbalances, the expression of miRNAs in blood or other body fluids changes significantly. Moreover, its stability, specificity, and selectivity make miRNAs ideal candidates for sepsis biomarkers. In conclusion, we can affirm that stable species of circulating miRNAs represent potential biomarkers for monitoring the evolution of sepsis. Twit Text FOAVip Use of miRNAs as Biomarkers in Sepsis ????Anal Cell Pathol (Amst) http://www.kidney.de/pget.php?&tw=1&pmid=26221578 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26221578 #FOAvip English Wikipedia <ref>{{Cite pmid|26221578}}</ref> Use of miRNAs as Biomarkers in Sepsis #MMPMID26221578 Dumache R; Rogobete AF; Bedreag OH; Sarandan M; Cradigati AC; Papurica M; Dumbuleu CM; Nartita R; Sandesc D Anal Cell Pathol (Amst) 2015[]; 2015 (ä): ä PMID26221578show ga Sepsis is one of the most common causes of death in critical patients. Severe generalized inflammation, infections, and severe physiological imbalances significantly decrease the survival rate with more than 50%. Moreover, monitoring, evaluation, and therapy management often become extremely difficult for the clinician in this type of patients. Current methods of diagnosing sepsis vary based especially on the determination of biochemical-humoral markers, such as cytokines, components of the complement, and proinflammatory and anti-inflammatory compounds. Recent studies highlight the use of new biomarkers for sepsis, namely, miRNAs. miRNAs belong to a class of small, noncoding RNAs with an approximate content of 19?23 nucleotides. Following biochemical and physiological imbalances, the expression of miRNAs in blood or other body fluids changes significantly. Moreover, its stability, specificity, and selectivity make miRNAs ideal candidates for sepsis biomarkers. In conclusion, we can affirm that stable species of circulating miRNAs represent potential biomarkers for monitoring the evolution of sepsis. äUse of miRNAs as Biomarkers in Sepsis (epmc).pdf DeepDyve Pubget Overpricing